Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2005; 11(19): 2892-2899
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2892
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2892
Table 2 Blood and renal routine and PT in two groups before treatment (mean±SD).
| Group | n | RBC (1012/L) | Hemoglobin (g/L) | WBC (109/L) | Platelet (109/L) | BUN (mmol/L) | Cr (mmol/L) | PT (s) |
| Experimental | 110 | 4.6±0.7 | 139.8±16.7 | 5.1±1.4 | 137.1±86.0 | 4.4±1.3 | 84.1±17.4 | 13.6±1.9 |
| Control | 106 | 4.5±0.7 | 138.9±16.5 | 5.0±1.4 | 117.8±48.1 | 4.7±1.6 | 86.9±21.0 | 13.5±1.7 |
| P | 0.499 | 0.761 | 0.499 | 0.054 | 0.193 | 0.441 | 0.168 |
- Citation: Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol 2005; 11(19): 2892-2899
- URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2892.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2892